BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5327103)

  • 21. The physiology of copper in man and its relation to Wilson's disease.
    Walshe JM
    Brain; 1967 Mar; 90(1):149-76. PubMed ID: 5336999
    [No Abstract]   [Full Text] [Related]  

  • 22. [EEG changes under sodium diethyldithiocarbamate therapy in 2 cases of Wilson's disease].
    Lang HD; Reichenmiller HE; Tigges FJ; Braun HJ; Golisch G
    Med Klin; 1972 Jun; 67(26):916-21. PubMed ID: 5048687
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of penicillamine on failure of renal acidification in Wilson's disease.
    Walshe JM
    Lancet; 1968 Apr; 1(7546):775-8. PubMed ID: 4171128
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatolemticular degeneration (Wison's disease): prolonged treatment with D-penicillamine in 3 cases].
    Balcells A; Cabrer B; Cano JF; Coll J; Ingelmo M; Vivancos J
    Rev Clin Esp; 1976 Oct; 143(2):157-64. PubMed ID: 1013453
    [No Abstract]   [Full Text] [Related]  

  • 25. [Fibrinolytic activity in patients with hepatolenticular degeneration: the effect of penicillamine].
    Babić T; Relja M
    Lijec Vjesn; 1988 Dec; 110(12):420-2. PubMed ID: 3246941
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases].
    Lange J
    Dtsch Med Wochenschr; 1967 Sep; 92(37):1657-62. PubMed ID: 6054323
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies with radioactive copper (64Cu and 67Cu) in relation to the natural history of Wilson's disease.
    Osborn SB; Walshe JM
    Lancet; 1967 Feb; 1(7486):346-50. PubMed ID: 4163882
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 29. Penicillamine in Wilson's disease.
    Danks DM
    Lancet; 1982 Aug; 2(8295):435-6. PubMed ID: 6124819
    [No Abstract]   [Full Text] [Related]  

  • 30. The discovery of the therapeutic use of D-penicillamine.
    Walshe JM
    J Rheumatol Suppl; 1981; 7():3-8. PubMed ID: 7014875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wilson's disease: assessment of D-penicillamine treatment.
    Van Caillie-Bertrand M; Degenhart HJ; Luijendijk I; Bouquet J; Sinaasappel M
    Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term therapy of Wilson's disease.
    Deiss A; Lynch RE; Lee GR; Cartwright GE
    Ann Intern Med; 1971 Jul; 75(1):57-65. PubMed ID: 4997065
    [No Abstract]   [Full Text] [Related]  

  • 33. [Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine].
    Gregersen G; Frederiksen G
    Ugeskr Laeger; 1971 Jul; 133(29):1406-9. PubMed ID: 5569040
    [No Abstract]   [Full Text] [Related]  

  • 34. Decreased taste sensitivity after D-penicillamine reversed by copper administration.
    Henkin RI; Keiser HR; Jafee IA; Sternlieb I; Scheinberg IH
    Lancet; 1967 Dec; 2(7529):1268-71. PubMed ID: 4168610
    [No Abstract]   [Full Text] [Related]  

  • 35. Wilson's disease: the role of penicillamine.
    Carmichael BM
    Mil Med; 1969 Oct; 134(11):1336-9. PubMed ID: 4980975
    [No Abstract]   [Full Text] [Related]  

  • 36. The renal clearance of amino acids in a patient with Wilson's disease during penicillamine treatment.
    Bell GE; Slivka DC; Huston JR
    J Lab Clin Med; 1968 Jan; 71(1):113-21. PubMed ID: 5634999
    [No Abstract]   [Full Text] [Related]  

  • 37. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

  • 38. [Wilson's disease (hepatolenticular degeneration)].
    Ferrer S; Grismali J; Vergara F; Madrid R; Colombo M
    Rev Med Chil; 1968 Dec; 96(12):779-88. PubMed ID: 5732518
    [No Abstract]   [Full Text] [Related]  

  • 39. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
    Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S
    Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current problems of Wilson's disease (hepatolenticular degeneration)].
    Julesz J; Bodor F; Szarvas F
    Orv Hetil; 1969 Dec; 110(49):2857-60. PubMed ID: 5364763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.